Sclerosing encapsulating peritonitis.
D000085:Acetates / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000891:Anti-Infective Agents, Local / Q000009:adverse effects; D001424:Bacterial Infections / Q000150:complications; D006801:Humans; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000209:etiology*; D013997:Time Factors
D000085:Acetates; D000319:Adrenergic beta-Antagonists; D000891:Anti-Infective Agents, Local